Mia's Feed
Medical News & Research

Decline in Flu Vaccination Rates Among U.S. Adults from 2020 to 2024

Decline in Flu Vaccination Rates Among U.S. Adults from 2020 to 2024

Share this article

A recent study highlights a significant decline in flu vaccine uptake among U.S. adults from 2020 to 2024, driven by shifting attitudes and misinformation. Learn more about this concerning trend.

2 min read

Between 2020 and 2024, there has been a notable decrease in influenza vaccine uptake among adults in the United States, as revealed by a recent study published in PLOS Global Public Health. Researchers Hannah Melchinger from UT Southwestern Medical Center and her team conducted two comprehensive, cross-sectional surveys to assess vaccination trends over these years.

In May 2020, more than 60% of U.S. adults surveyed reported having received or intending to receive the flu vaccine in the upcoming months. However, by October 2024, this figure dropped to 54%, indicating a substantial decline in vaccination willingness. The decrease was particularly evident among demographic groups typically showing higher vaccination rates. Older adults over 35 years experienced an 11% reduction, males saw a 13% decline, and white, non-Hispanic, and more highly educated individuals also exhibited decreased vaccination rates.

The authors attribute this downward trend to shifting attitudes and intentions related to vaccination, influenced heavily by the COVID-19 pandemic. Factors such as perceived risk changes, widespread vaccine misinformation, and disinformation appears to have contributed to the hesitation and reduced uptake.

This trend raises concerns about public health preparedness and highlights the importance of addressing vaccine misinformation and improving vaccination campaigns to protect vulnerable populations against seasonal influenza.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

FDA Approves Innovative AI Platform for Breast Cancer Risk Prediction

The FDA has authorized CLAIRITY BREAST, the first AI-based platform to predict breast cancer risk from routine mammograms, enabling earlier and more personalized detection strategies.

California Expands Use of Artificial Turf: Weighing Environmental and Health Impacts

California's rapid adoption of synthetic turf in schools and parks raises concerns over extreme heat, chemical exposure, and environmental impacts. Learn about the ongoing debates and health risks associated with artificial turf.

Potential Impact of GLP-1 Receptor Agonists on Diabetic Retinopathy Incidence and Outcomes

New research reveals that GLP-1 receptor agonists may slightly increase diabetic retinopathy incidence but could reduce severe eye complications, emphasizing the importance of regular eye screening for diabetics.

Risks of Melatonin Gummies for Children: Overdose Concerns Lead to Store Suspension

An online store has suspended sales of melatonin gummies after reports of overdose in children, raising safety concerns about non-prescription sleep aids for kids.